These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 22503123)

  • 1. Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.
    Dirks MS; Butman JA; Kim HJ; Wu T; Morgan K; Tran AP; Lonser RR; Asthagiri AR
    J Neurosurg; 2012 Jul; 117(1):109-17. PubMed ID: 22503123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth Dynamics of Intracranial Tumors in Patients with Neurofibromatosis Type 2.
    Lawson McLean AC; Rosahl SK
    World Neurosurg; 2017 Feb; 98():152-161. PubMed ID: 27777160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.
    Holman MA; Schmitt WR; Carlson ML; Driscoll CL; Beatty CW; Link MJ
    J Neurosurg Pediatr; 2013 Oct; 12(4):317-24. PubMed ID: 23909617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2007 Dec; 28(8):1083-90. PubMed ID: 18043434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype.
    Aghi M; Kluwe L; Webster MT; Jacoby LB; Barker FG; Ojemann RG; Mautner VF; MacCollin M
    J Neurosurg; 2006 Feb; 104(2):201-7. PubMed ID: 16509493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
    Abi Jaoude S; Peyre M; Degos V; Goutagny S; Parfait B; Kalamarides M
    J Neurosurg; 2021 May; 134(5):1377-1385. PubMed ID: 32442973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brigatinib in
    Plotkin SR; Yohay KH; Nghiemphu PL; Dinh CT; Babovic-Vuksanovic D; Merker VL; Bakker A; Fell G; Trippa L; Blakeley JO;
    N Engl J Med; 2024 Jun; 390(24):2284-2294. PubMed ID: 38904277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
    Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the growth rate of vestibular schwannoma in patients with neurofibromatosis type 2.
    Li H; Hao SY; Wang L; Li D; Wu Z; Zhang LW; Zhang JT
    Acta Neurochir (Wien); 2015 Nov; 157(11):1983-90. PubMed ID: 26287269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course and management of intracranial meningiomas in neurofibromatosis type 2 patients.
    Nowak A; Dziedzic T; Czernicki T; Kunert P; Marchel A
    Neurol Neurochir Pol; 2015; 49(6):367-72. PubMed ID: 26652870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial meningiomas and neurofibromatosis type 2.
    Aboukais R; Zairi F; Baroncini M; Bonne NX; Schapira S; Vincent C; Lejeune JP
    Acta Neurochir (Wien); 2013 Jun; 155(6):997-1001; discussion 1001. PubMed ID: 23558725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vestibular schwannoma growth rates in neurofibromatosis type 2 natural history consortium subjects.
    Slattery WH; Fisher LM; Iqbal Z; Oppenhiemer M
    Otol Neurotol; 2004 Sep; 25(5):811-7. PubMed ID: 15354016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of newly developed NF2 intracranial meningiomas through comparative analysis of pediatric and adult patients.
    Li P; Wu T; Wang Y; Zhao F; Wang Z; Wang X; Wang B; Yang Z; Liu P
    Clin Neurol Neurosurg; 2020 Jul; 194():105799. PubMed ID: 32229353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients.
    Nunes FP; Merker VL; Jennings D; Caruso PA; di Tomaso E; Muzikansky A; Barker FG; Stemmer-Rachamimov A; Plotkin SR
    PLoS One; 2013; 8(3):e59941. PubMed ID: 23555840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of multiple tumors in neurofibromatosis type 2 patients.
    Aboukais R; Bonne NX; Baroncini M; Zairi F; Schapira S; Vincent C; Lejeune JP
    Neurochirurgie; 2018 Nov; 64(5):364-369. PubMed ID: 26071178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis type 2.
    Slattery WH
    Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term growth rate of vestibular schwannoma in neurofibromatosis 2: A volumetric consideration.
    Picry A; Bonne NX; Ding J; Aboukais R; Lejeune JP; Baroncini M; Dubrulle F; Vincent C
    Laryngoscope; 2016 Oct; 126(10):2358-62. PubMed ID: 27075822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
    Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
    J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.